Enter to open, tab to navigate, enter to select
Antitrust risk-shifting provisions in Fluidigm Corporation/DVS Sciences, Inc. merger agreement
| January 28, 2014 • Antitrust Risk-shifting • $207.5 million (subject to purchase price adjustment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.